4.7 Article

Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7

Journal

FASEB JOURNAL
Volume 35, Issue 11, Pages -

Publisher

WILEY
DOI: 10.1096/fj.202100766RR

Keywords

angiotensin II; hypertension; miR-214; Smad7; vascular remodeling

Funding

  1. National Natural Science Foundation of China (NSFC) [81822026, 91740114, 81470429]
  2. State Key Lab of Space Medicine Fundamentals and Application [SMFA16B03, SMFA17B05, SMFA18B08, SMFA19A02]

Ask authors/readers for more resources

The knockout of miR-214 in VSMCs significantly alleviates Ang II-induced hypertension, reduces systolic blood pressure, inhibits vascular medial thickness, blunts the response of blood vessels to various stimuli, and reverses vascular dysfunction. The mechanism involves a crosstalk between AT1R signaling and TGF-beta/Smad signaling pathways. The results suggest that miR-214 could be a potential therapeutic target for hypertension treatment.
Vascular remodeling is a prominent trait during the development of hypertension, attributable to the phenotypic transition of vascular smooth muscle cells (VSMCs). Increasing studies demonstrate that microRNA plays an important role in this process. Here, we surprisingly found that smooth muscle cell-specific miR-214 knockout (miR-214 cKO) significantly alleviates angiotensin II (Ang II)-induced hypertension, which has the same effect as that of miR-214 global knockout mice in response to Ang II stimulation. Under the treatment of Ang II, miR-214 cKO mice exhibit substantially reduced systolic blood pressure. The vascular medial thickness and area in miR-214 cKO blood vessels were obviously reduced, the expression of collagen I and proinflammatory factors were also inhibited. VSMC-specific deletion of miR-214 blunts the response of blood vessels to the stimulation of endothelium-dependent and -independent vasorelaxation and phenylephrine and 5-HT induced vasocontraction. In vitro, Ang II-induced VSMC proliferation, migration, contraction, hypertrophy, and stiffness were all repressed with miR-214 KO in VSMC. To further explore the mechanism of miR-214 in the regulation of the VSMC function, it is very interesting to find that the TGF-beta signaling pathway is mostly enriched in miR-214 KO VSMC. Smad7, the potent negative regulator of the TGF-beta/Smad pathway, is identified to be the target of miR-214 in VSMC. By which, miR-214 KO sharply enhances Smad7 levels and decreases the phosphorylation of Smad3, and accordingly alleviates the downstream gene expression. Further, Ang II-induced hypertension and vascular dysfunction were reversed by antagomir-214. These results indicate that miR-214 in VSMC established a crosstalk between Ang II-induced AT1R signaling and TGF-beta induced T beta RI /Smad signaling, by which it exerts a pivotal role in vascular remodeling and hypertension and imply that miR-214 has the potential as a therapeutic target for the treatment of hypertension.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available